ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer
27 mars 2017 07h00 HE
|
ProQR Therapeutics
LEIDEN, the Netherlands, March 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that it appointed David M. Rodman, MD as Chief Development Strategy Officer. Dr....